Zecotek Ships Over US$225,000 of LFS Scintillation Crystals
VANCOUVER, Sept. 11, 2018 /CNW/ - Zecotek Photonics Inc. ("Zecotek" or the "Company") (TSX-V: ZMS) (TSX-V: ZMS.V) (Frankfurt: W1I) (OTCPK: ZMSPF), a developer of leading-edge photonics technologies for healthcare, industrial and scientific markets, is pleased to announce that it has shipped over $225,000 worth of its patented LFS scintillation crystals from recently announced orders. The initial crystal shipments are for a new line of positron emission tomography (PET) medical scanners.
"We have shipped over US$225,000 from recent orders of our patented LFS scintillation crystals for a new line generation positron emission tomography medical scanners and shipments will increase as the new facility in Shanghai ramps up crystal production," said Dr. A.F. Zerrouk, Chairman, President, and CEO of Zecotek Photonics Inc. "I am very pleased with our progress towards becoming a leading LFS crystal supplier in China and look forward as our manufacturing capacity increases to take on the North American and European markets."
Zecotek Imaging China, a subsidiary of Zecotek Imaging Systems (Singapore), is commercializing patented LFS scintillation crystals through its new production facility in Shanghai, China. Zecotek Imaging China is poised to become a leader in large-scale production, cutting and polishing of scintillation crystals grown by the Czochralski method in China. Using a proprietary manufacturing process, very large-diameter boules with uniform properties and without cracks are produced resulting in high element output with lower unit costs.
The ISO certified LFS Crystal Production Facility has sufficient capacity to meet the delivery schedule of our Tier 1 clients and will be expanded to meet growing demand in late 2018 and early 2019.
The LFS series of scintillation crystals are known to be uniquely qualified for components in PET medical scanners. LFS crystals have the fastest decay parameter in their category, the best energy resolution and competitive pricing, which are key attributes for the new configurations of high resolution Time Of Flight PET scanners. PET OEMs have conducted comparative tests with other many other scintillation materials and recognize Zecotek's LFS crystals to be superior for specific designs of PET medical scanners.
Cutting, polishing and array assembly will also be done at the production facility in Shanghai. Zecotek has developed a proprietary automated manufacturing process that uses robotics to assemble the LFS crystal arrays. The automated process will translate into faster manufacturing of arrays and improve the performance of the arrays with repeatable uniformity and much greater accuracy.
Zecotek's LFS series of scintillation crystals are protected in China and jurisdictions around globe by a worldwide patent (including US patent No. 7,132,060). The crystals cover a wide range of emission wavelengths which can be tailored to match the spectral sensitivity of various photo detectors including Zecotek's own solid-state MAPD/T photo detector arrays.
Zecotek is focused on of becoming a leading supplier of scintillation crystals and other key photonic components in China and around the world.
Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I; OTCPK: ZMSPF) is a photonics technology company developing high-performance scintillation crystals, solid-state photo detectors, 3D displays and related technologies for applications in medical, high-tech and industrial sectors. Founded in 2004, Zecotek has three operating divisions: Zecotek Imaging Systems, Zecotek Optronics Systems, and Zecotek Autotronics with labs located in Canada, Korea, Russia, Singapore and U.S.A. It is commercializing over 55 patented and patent pending novel photonic technologies directly and through strategic alliances with the Shanghai EBO Optoelectronics Technology Company (China), Hamamatsu Photonics (Japan), the European Organization for Nuclear Research (Switzerland), NuCare Medical Systems (South Korea), the University of Washington (United States), and National NanoFab Center (South Korea). For more information visit www.zecotek.com and follow @zecotek on Twitter.
This press release may contain forward-looking statements that are based on management's expectations, estimates, projections and assumptions. These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Therefore, actual future results and trends may differ materially from what may have been stated.
Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of the content of this news release. If you would like to receive news from Zecotek in the future, please visit the corporate website at www.zecotek.com.
SOURCE Zecotek Photonics Inc